Lobular carcinoma in situ. Long term follow-up

Authors

  • Robert V. P. Hutter MD,

    Corresponding author
    1. Department of Pathology, Memorial Hospital for Cancer and Allied Diseases
    Current affiliation:
    1. Professor and Director of Anatomical Pathology and Cytopathology, Yale University School of Medicine, New Haven, Conn.
    • Department of Pathology, Memorial Hospital, 444 East 68th St., New York, N.Y. 10021
    Search for more papers by this author
  • Frank W. Foote Jr. MD

    1. Department of Pathology, Memorial Hospital for Cancer and Allied Diseases
    Search for more papers by this author

Abstract

Current follow-up information is presented on a unique group of 46 patients first diagnosed as having lobular carcinoma in situ during the period 1940-1952 and observed from 4 to 27 years. Six patients each had radical mastectomy; the remaining 40 had no treatment after a diagnostic biopsy. Subsequent cancers developed in 33% (15/46) patients. The 15 patients developed 20 cancers; an incidence of 13% (6/46) bilaterality. Seventy-five percent (15/20) of the cancers were infiltrating. Two patients (4%) are dead from metastatic breast cancer; 2 others (4%) are living with metastases. Only half of the 20 cancers appeared in die first decade and the remaining half appeared up to 22 years after the original diagnosis of lobular carcinoma in situ. The evidence continues to accrue proving that lobular carcinoma in situ is a preinvasive form of breast cancer which should be treated by modified radical mastectomy.

Ancillary